N6-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
Open Access
- 14 April 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in Military Medical Research
- Vol. 9 (1), 1-16
- https://doi.org/10.1186/s40779-022-00378-z
Abstract
Stemness and chemoresistance contribute to cervical cancer recurrence and metastasis. In the current study, we determined the relevant players and role of N6-methyladenine (m6A) RNA methylation in cervical cancer progression. The roles of m6A RNA methylation and centromere protein K (CENPK) in cervical cancer were analyzed using bioinformatics analysis. Methylated RNA immunoprecipitation was adopted to detect m6A modification of CENPK mRNA. Human cervical cancer clinical samples, cell lines, and xenografts were used for analyzing gene expression and function. Immunofluorescence staining and the tumorsphere formation, clonogenic, MTT, and EdU assays were performed to determine cell stemness, chemoresistance, migration, invasion, and proliferation in HeLa and SiHa cells, respectively. Western blot analysis, co-immunoprecipitation, chromatin immunoprecipitation, and luciferase reporter, cycloheximide chase, and cell fractionation assays were performed to elucidate the underlying mechanism. Bioinformatics analysis of public cancer datasets revealed firm links between m6A modification patterns and cervical cancer prognosis, especially through ZC3H13-mediated m6A modification of CENPK mRNA. CENPK expression was elevated in cervical cancer, associated with cancer recurrence, and independently predicts poor patient prognosis [hazard ratio = 1.413, 95% confidence interval = 1.078 − 1.853, P = 0.012]. Silencing of CENPK prolonged the overall survival time of cervical cancer-bearing mice and improved the response of cervical cancer tumors to chemotherapy in vivo (P < 0.001). We also showed that CENPK was directly bound to SOX6 and disrupted the interactions of CENPK with β-catenin, which promoted β-catenin expression and nuclear translocation, facilitated p53 ubiquitination, and led to activation of Wnt/β-catenin signaling, but suppression of the p53 pathway. This dysregulation ultimately enhanced the tumorigenic pathways required for cell stemness, DNA damage repair pathways necessary for cisplatin/carboplatin resistance, epithelial-mesenchymal transition involved in metastasis, and DNA replication that drove tumor cell proliferation. CENPK was shown to have an oncogenic role in cervical cancer and can thus serve as a prognostic indicator and novel target for cervical cancer treatment.Keywords
Funding Information
- Joint Funds for the Innovation of Science and Technology Program of Fujian Province (2018Y9110)
- Natural Science Foundation of Fujian Province (2020J011126)
- China Postdoctoral Science Foundation (2021T140468)
This publication has 45 references indexed in Scilit:
- SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem CellsCancer Research, 2017
- Overexpression of centromere protein K (CENP-K) gene in hepatocellular carcinoma promote cell proliferation by activating AKT/TP53 signal pathwayOncotarget, 2017
- Overexpression of centromere protein K (CENPK) in ovarian cancer is correlated with poor patient survival and associated with predictive and prognostic relevancePeerJ, 2015
- Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomasOncotarget, 2015
- Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppressionOncogene, 2015
- Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo studyBMC Cancer, 2015
- Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysisInternational Journal of Oncology, 2012
- The CENP-H–I complex is required for the efficient incorporation of newly synthesized CENP-A into centromeresNature, 2006
- Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.2002
- Classification of Sensitivity or Resistance of Cervical Cancers to Ionizing Radiation According to Expression Profiles of 62 Genes Selected by cDNA Microarray AnalysisNeoplasia, 2002